CVR: 40594132
Previous names: CytoKi Pharma ApS
Cytoki Pharma ApS was a Danish company of the type Anpartsselskab based in Søborg, founded in 2019. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CytoKi Pharma ApS. The management consists of Anders Hagstrøm. The company's owners include LUNDBECKFOND INVEST A/S, 15-Bio ApS and YSIOS Biofund III, F.C.R.E. In 2025, the company reported a gross profit of DKK -42,198,706 and a net result of DKK -43,800,007 compared with DKK -39,261,697 the year before. Equity amounted to DKK 13,473,548.
Selskabets formål er forskning, udvikling, fremstilling og kommercialisering af proteinbaserede lægemidler og hermed efter bestyrelsens skøn stående relateret virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -42.2 mio. | -43.8 mio. | 18 mio. | 13.5 mio. | 4 | |
| 2024 | -39.1 mio. | -39.3 mio. | 62.9 mio. | 57.3 mio. | 4 | |
| 2023 | -61.5 mio. | -64.5 mio. | 73.9 mio. | 66.7 mio. | 5 | |
| 2022 | -98.8 mio. | -98.4 mio. | 68.9 mio. | 51.2 mio. | 4 | |
| 2021 | -32 mio. | -29.8 mio. | 116.2 mio. | 106.8 mio. | 3 | |
| 2020 | -6 mio. | -6.8 mio. | 7 mio. | -9.8 mio. | 1 |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.053 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Contact info changed: new email: [email protected] (April 9, 2026).
On April 9, 2026, Cytoki Pharma ApS entered liquidation.
Cytoki Pharma ApS has published its annual report for 2025. Gross profit came to DKK -42,198,706, and the net result was DKK -43,800,007.
As of March 31, 2026, Christian Ellebæk Elling has left the board of directors of Cytoki Pharma ApS.
As of March 31, 2026, Karen Ina Barbara Wagner has left the board of directors of Cytoki Pharma ApS.
As of March 31, 2026, Annegret Elisabeth De Baey-Diepolder has left the board of directors of Cytoki Pharma ApS.
As of March 31, 2026, Klaus Andreas Dugi has left the board of directors of Cytoki Pharma ApS.
As of March 31, 2026, Anders Hagstrøm is registered as liquidator of Cytoki Pharma ApS.
As of March 31, 2026, Rasmus Jørgensen has stepped down as adm. dir. of Cytoki Pharma ApS.
On March 31, 2026, Cytoki Pharma ApS entered liquidation.
Cytoki Pharma ApS has published its annual report for 2024. Gross profit came to DKK -39,132,575, and the net result was DKK -39,261,697.
As of May 8, 2024, is registered as an owner of Cytoki Pharma ApS with an ownership share of 15%.
As of May 8, 2024, is registered as an owner of Cytoki Pharma ApS with an ownership share of 20%.
As of May 8, 2024, is registered as an owner of Cytoki Pharma ApS with an ownership share of 5%.
As of April 1, 2024, Klaus Andreas Dugi has joined the board of directors of Cytoki Pharma ApS.
As of March 31, 2024, Daniel Bach Gonzalez has left the board of directors of Cytoki Pharma ApS.
Cytoki Pharma ApS has published its annual report for 2023. Gross profit came to DKK -61,547,808, and the net result was DKK -64,519,466.
As of July 17, 2023, Annegret Elisabeth De Baey-Diepolder has joined the board of directors of Cytoki Pharma ApS.
As of July 17, 2023, Amanda Viven Gett-Chaperot has left the board of directors of Cytoki Pharma ApS.
Cytoki Pharma ApS has published its annual report for 2022. Gross profit came to DKK -98,763,646, and the net result was DKK -98,393,590.
On May 16, 2023, the company changed its name from CytoKi Pharma ApS to Cytoki Pharma ApS.
As of December 19, 2022, 15-Bio ApS is registered as an owner of Cytoki Pharma ApS with an ownership share of 10%.
Cytoki Pharma ApS has published its annual report for 2021. Gross profit came to DKK -31,975,161, and the net result was DKK -29,753,257.
Cytoki Pharma ApS has published its annual report for 2020. Gross profit came to DKK -6,039,747, and the net result was DKK -6,793,432.
As of June 21, 2021, is registered as an owner of Cytoki Pharma ApS with an ownership share of 5%.
As of June 21, 2021, is registered as an owner of Cytoki Pharma ApS with an ownership share of 5%.
As of April 28, 2021, Christian Ellebæk Elling has joined the board of directors of Cytoki Pharma ApS.
As of April 28, 2021, Karen Ina Barbara Wagner has joined the board of directors of Cytoki Pharma ApS.
As of April 28, 2021, Amanda Viven Gett-Chaperot has joined the board of directors of Cytoki Pharma ApS.
As of April 28, 2021, Daniel Bach Gonzalez has joined the board of directors of Cytoki Pharma ApS.
As of April 28, 2021, LUNDBECKFOND INVEST A/S is registered as an owner of Cytoki Pharma ApS with an ownership share of 25%.
Cytoki Pharma ApS has published its interim report for the period June 12, 2019 – December 31, 2019.
As of August 24, 2020, Rasmus Jørgensen has left the board of directors of Cytoki Pharma ApS.
As of August 24, 2020, Susanne Jørgensen has left the board of directors of Cytoki Pharma ApS.
As of August 13, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Cytoki Pharma ApS.
As of August 13, 2019, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Cytoki Pharma ApS.
As of June 12, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of Cytoki Pharma ApS.
As of June 12, 2019, Rasmus Jørgensen has joined the board of directors of Cytoki Pharma ApS.
As of June 12, 2019, Susanne Jørgensen has joined the board of directors of Cytoki Pharma ApS.
As of June 12, 2019, Rasmus Jørgensen is registered as adm. dir. of Cytoki Pharma ApS.
Cytoki Pharma ApS was founded on June 12, 2019.
Companies in the same industry and area
CVR 37918806
CVR 45943062
CVR 41093447
CVR 39119374
CVR 32887082
companydata.dk